To document whether c-erbB-2 over-expression or p53 accumulation in tumour cells was predictive of response to chemo-or radiotherapy, we analyzed a population of patients with breast cancer assigned to neo-adjuvant therapy (median follow-up: 54 months). T2/T3-N0N1b-M0 tumours (329 cases) were treate
50 Predictive value of p53, C-erbB-2 and VEGF expression on adjuvant chemotherapy in NSCLC
โ Scribed by Wu, Yi-Iong; Yu, Hui
- Book ID
- 123365816
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 344 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was p
## Abstract ## Background and Objectives p53 tumor suppressor gene has a dual role as a trigger of apoptosis and as an initiator of DNA repair. The Bclโ2 can work to protect cells from apoptosis, which is induced by p53 gene. These facts suggest the significant role of these genes in the genesis a